11 May 2021 | News
No blood clots or other adverse reactions to the vaccine were observed in ferrets during the study
Image credit- shutterstock.com
The Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia’s national science agency, has published the peer-reviewed results of its independent preclinical evaluation of the University of Oxford-AstraZeneca (AZ) COVID-19 vaccine in an animal model, conducted in early 2020.
The study was conducted in partnership with the Coalition for Epidemic Preparedness Innovations (CEPI). Quality assured and quality-controlled data was shared last year with CEPI and the University of Oxford to support human clinical trials.
No blood clots or other adverse reactions to the vaccine were observed in ferrets during the study.
The preclinical study evaluated the efficacy of the vaccine when delivered in one or two doses, through either an intramuscular injection or by nasal drops.
The study found:
The study took place at the Australian Centre for Disease Preparedness, CSIRO’s high-containment biosecurity facility in Geelong.